Dual Effects of 3-epi-betulin from Daphniphyllum glaucescens in Suppressing SARS-CoV-2-Induced Inflammation and Inhibiting Virus Entry
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242317040 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yung-Ju Yeh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404328, Taiwan. Hauptthemen laut MEDLINE: COVID-19, Daphniphyllum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Medical University(Taiwan), National Science and Technology Council(Taiwam), Chang Gung Medical Foundation(Taiwan).
Abstract (Originalsprache)
The continuous emergence of SARS-CoV-2 variants has led to a protracted global COVID-19 pandemic with significant impacts on public health and global economy. While there are currently available SARS-CoV-2 vaccines and therapeutics, most of the FDA-approved antiviral agents directly target viral proteins. However, inflammation is the initial immune pathogenesis induced by SARS-CoV-2 infection, there is still a need to find additional agents that can control the virus in the early stages of infection to alleviate disease progression for the next pandemic. Here, we find that both the spike protein and its receptor CD147 are crucial for inducing inflammation by SARS-CoV-2 in THP-1 monocytic cells. Moreover, we find that 3-epi-betulin, isolated from Daphniphyllum glaucescens, reduces the level of proinflammatory cytokines induced by SARS-CoV-2, consequently resulting in a decreased viral RNA accumulation and plaque formation. In addition, 3-epi-betulin displays a broad-spectrum inhibition of entry of SARS-CoV-2 pseudoviruses, including Alpha (B.1.1.7), Eplison (B.1.429), Gamma (P1), Delta (B.1.617.2) and Omicron (BA.1). Moreover, 3-epi-betulin potently inhibits SARS-CoV-2 infection with an EC50 of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404328, Taiwan.
- Research Center for Emerging Viruses, China Medical University Hospital, Taichung 404328, Taiwan.
- Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 100229, Taiwan.
- The Ph.D. Program of Biotechnology and Biomedical Industry, China Medical University, Taichung 404328, Taiwan.
- Department of Laboratory Medicine, National Taiwan University Hospital and National Taiwan University College Medicine, Taipei 100229, Taiwan.
- Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu 300093, Taiwan.
ORCID-Profile: Yung-Ju Yeh, Chih-Hua Chao, Ching-Ping Tseng
Förderung
- China Medical University(Taiwan)
- National Science and Technology Council(Taiwam)
- Chang Gung Medical Foundation(Taiwan)
- China Medical University Hospital
Zitieren
APA
Yeh, Y. J., Chao, T. L., Chang, Y. J., Chang, S. Y., Lu, C. H., Chao, C. H., Su, W. C., Tseng, C. P., Lai, M. M. C., & Cheng, J. C. (2023). Dual Effects of 3-epi-betulin from Daphniphyllum glaucescens in Suppressing SARS-CoV-2-Induced Inflammation and Inhibiting Virus Entry. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242317040
Vancouver
Yeh YJ, Chao TL, Chang YJ, Chang SY, Lu CH, Chao CH, et al. Dual Effects of 3-epi-betulin from Daphniphyllum glaucescens in Suppressing SARS-CoV-2-Induced Inflammation and Inhibiting Virus Entry. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242317040
BibTeX
@article{Yeh2023,
author = {Yeh, Yung-Ju and Chao, Tai-Ling and Chang, Yu-Jen and Chang, Sui-Yuan and Lu, Chih-Hao and Chao, Chih-Hua and Su, Wen-Chi and Tseng, Ching-Ping and Lai, Michael M C and Cheng, Ju-Chien},
title = {Dual Effects of 3-epi-betulin from Daphniphyllum glaucescens in Suppressing SARS-CoV-2-Induced Inflammation and Inhibiting Virus Entry},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242317040}
}
EUVIMED